Medisafe builds medication-management digital drug companions and deploys AI-driven personalization (JITI™) to support patients across their therapy journeys. The platform has over 7M registered users and a database of more than four billion dosage behaviors that inform its Just-in-Time-Interventions engine. Medisafe partners with global pharma companies and is expanding opportunities across the broader health ecosystem. Product offerings include Medisafe Care Connector, launched in 2020 to link clinicians into patient support programs, and Maestro, a proprietary no-code technology for building and optimizing personalized journeys introduced last September. The company is led by CEO Omri Shor and was founded in 2012. It intends to use new funding to expand end-to-end solutions and accelerate revenue growth. Medisafe is a Boston-based personalized medication management platform that addresses major causes of medication non-adherence. Its cloud-based mobile platform personalizes content, resources and interventions, including educational videos, coupons and motivational messages, based on each user’s regimen, condition and circumstances. The platform runs on iOS and Android and has been used by over 3.5 million patient and caregiver registered users who have recorded over 500 million medication doses and contributed 140,000 app-store reviews. Led by CEO and co-founder Omri Shor, the company plans to use new funding to expand sales, marketing and engineering teams. Medisafe also intends to open a European office to support international growth. These moves are aimed at scaling operations and increasing adoption of its medication‑adherence tools. MediSafe is a mobile-first medication management platform that reminds patients to take medications and alerts caregivers when doses are missed. The company delivers personalized interventions addressing forgetfulness, lack of support, emotional distress, information overload, low engagement, and medication cost barriers. Its platform enables tighter care coordination between patients, “MedFriends” (caregivers), physicians, and other providers. MediSafe reports more than 1.3 million downloads across iOS and Android and about 52,000 ratings averaging 4.5 out of 5. The company has won multiple industry awards and recognition for its mHealth solution. MediSafe plans to expand its suite of medication-management solutions, enhance user experience in its apps, accelerate U.S. user growth, and pursue distribution, technology, and data partnerships as part of its market expansion. MediSafe provides a cloud-synced mobile medication management app that reminds patients when to take medications and sends alerts to caretakers if doses are missed. The platform anonymously aggregates de-identified, self-reported user data and reports an 86% adherence rate among its users. MediSafe plans to use recent funding to build partnership programs with pharmaceutical companies, pharmacies, HMOs, employers and hospitals to better manage medication adherence. The company positions its analytics to give healthcare leaders insight into patient behavior and the issue of non-adherence. MediSafe was co-founded in mid 2012, graduated from the Microsoft Ventures Accelerator, and has seen growth in user adoption and satisfaction. The $1 million funding is intended to support product enhancements, partnership development, and continued expansion of its analytics capabilities.

Total raised

$52M

Funding rounds

4

Latest round

Series C

Latest activity

Feb 2021